Search

Memorial Sloan Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features as well as the availability of an on-site broadcast studio.

… Tuesday, August 27, 2013 Memorial Sloan Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and “trending topics” – a continually updated listing of story ideas and available experts to comment on the latest health

Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.

… Friday, January 1, 2021 Thank you to our donor community. Your commitment to supporting Memorial Sloan Kettering Cancer Center is essential to advancing our mission. Read more to learn about your impact in 2021. Fundraising Events at MSK Fred’s Team Participants raised more than $7.3 million in 2021

Learn why Bobby Logan chose active surveillance for his prostate cancer, and how he was successfully treated after his tumor changed.

… Friday, September 24, 2021 Urologist Behfar Ehdaie believes that active surveillance is a viable option for many patients with prostate cancer . He feels so strongly about this idea that several years ago, he sought out negotiation experts from Harvard Business School and asked to learn techniques he

Researchers at Memorial Sloan Kettering (MSK) reported results, which were highlighted at the American Society of Clinical Oncology (ASCO) press cast, that eight weeks of acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia in cancer survivors. While both acupuncture and CBT-I resulted in clinically meaningful and durable effects among this group, CBT-I was more effective, especially among people with mild insomnia symptoms.

… Wednesday, May 16, 2018 Researchers at Memorial Sloan Kettering (MSK) reported results, which were highlighted at the American Society of Clinical Oncology (ASCO) press cast, that eight weeks of acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia in cancer

New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75.

… Monday, October 6, 2008 New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients who began screenings at age 50 and have had consistently

As 2019 comes to an end, take a moment to reflect on the science stories that made the year one to remember.

… Monday, December 16, 2019 Many medical breakthroughs blossom from the seeds of basic science research. This past year, Memorial Sloan Kettering scientists made fundamental discoveries in several basic science fields, including cell biology, molecular biology, developmental biology, and more. Much of

The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed 16 students to our annual Summer Undergraduate Research Program.

… Tuesday, June 14, 2016 Sixteen undergraduate students arrived on June 6, 2016, to begin their Summer Undergraduate Research Program (SURP) under the auspices of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. They were greeted by GSK Associate Dean Linda Burnley and SURP faculty

Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.

… Wednesday, August 17, 2022 More than half of all cancers have mutations in a gene called p53 . The protein made from this gene is what’s called a tumor suppressor: When working properly, it guards against cancer development — in part, by detecting damaged DNA and alerting cells to repair it. Cells without

Recent advances in technology allow Memorial Sloan Kettering Cancer Center pathologists to perform swift and accurate molecular analyses of tumor cells in patients with colorectal cancer. By determining the gene mutations of individual tumors, doctors are able to prescribe treatments that are most likely to be effective for patients, while avoiding drugs that will provide no benefit and may cause serious side effects.

… Friday, October 1, 2010 Recent advances in technology allow Memorial Sloan Kettering Cancer Center pathologists to perform swift and accurate molecular analyses of tumor cells in patients with colorectal cancer. By determining the gene mutations of individual tumors, doctors may be able to prescribe

An MSK clinical trial is helping Gail Goode overcome multiple myeloma and sheds new light on how cancer affects people of diverse ethnic backgrounds.

… Tuesday, September 3, 2024 There is an urgent need to recruit more diverse patients into cancer clinical trials . One reason it’s so important is that researchers are learning that certain types of cancer occur more frequently in people with certain ancestries. For example:   African — people of African